Skip to main content

Table 3 Side effects of the modified MCTKD in patients of different age groups

From: Efficacy and safety of modified medium-chain triglyceride ketogenic diet in patients with drug-resistant epilepsy

Side effects

Cases (incidence)

 

 < 18 years (69 cases)

 ≥ 18 years (54 cases)

Total (123 cases)

P value

Diarrhea

1 (1.45%)

4 (7.41%)

5 (4.07%)

 

Abdominal pain

2 (2.90%)

2 (3.70%)

4 (3.25%)

 

Diarrhea&abdominal pain

0 (0.00%)

3 (5.56%)

3 (2.44%)

 

Vomiting

1 (1.45%)

1 (1.85%)

2 (1.63%)

 

Constipation

2 (2.90%)

2 (3.70%)

4 (3.25%)

 

Fever

0 (0.00%)

1 (1.85%)

1 (0.81%)

 

Rash

0 (0.00%)

1 (1.85%)

1 (0.81%)

 

Hyperuricemia

2 (2.90%)

0 (0.00%)

2 (1.63%)

 

Allergy

0 (0.00%)

1 (1.85%)

1 (0.81%)

 

Iron deficiency

1 (1.45%)

0 (0.00%)

1 (0.81%)

 

Fatigue

1 (1.45%)

1 (1.85%)

2 (1.63%)

 

Total

10 (14.49%)

16 (29.63%)

26 (21.14%)

0.041